PRHC
MD icon

P.R. Herzig & Co’s Pediatrix Medical MD Stock Holding History

P.R. Herzig & Co’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,310
Closed -$230K – 51
2017
Q1 		$230K Hold
3,310
– – 0.45% 45
2016
Q4 		$221K Sell
3,310
-3,240
-49% -$211K 0.45% 45
2016
Q3 		$434K Buy
6,550
+3,250
+98% +$222K 0.85% 38
2016
Q2 		$239K Buy
+3,300
New +$227K 0.5% 46

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

P.R. Herzig & Co's MD Position: Q2 2017 in Review

P.R. Herzig & Co sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 3,310 shares — an estimated $230K sold.

P.R. Herzig & Co first reported a position in MD in Q2 2016 and held it in 4 quarters. The position peaked at $434K in Q3 2016. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

  • P.R. Herzig & Co reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
  • P.R. Herzig & Co sold 3,310 Pediatrix Medical shares in Q2 2017, an estimated $230K.
  • P.R. Herzig & Co first reported a position in Pediatrix Medical in Q2 2016 and held it in 4 quarters.
  • P.R. Herzig & Co's Pediatrix Medical position peaked at $434K in Q3 2016.
  • 332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on P.R. Herzig & Co's 13F filing for Q2 2017, filed 18 Jul 2017.